Rikoon Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$764K Sell
12,486
-220
-2% -$12.1K 0.2% 115
2020
Q4
$686K Sell
12,706
-1,315
-9% -$68.2K 0.19% 114
2020
Q3
$658K Buy
14,021
+708
+5% +$36.3K 0.2% 108
2020
Q2
$700K Buy
13,313
+4
+0% +$206 0.23% 100
2020
Q1
$644K Sell
13,309
-196
-1% -$10.2K 0.27% 90
2019
Q4
$689K Buy
13,505
+604
+5% +$31.2K 0.24% 104
2019
Q3
$614K Sell
12,901
-400
-3% -$18.3K 0.23% 104
2019
Q2
$632K Sell
13,301
-261
-2% -$12K 0.24% 96
2019
Q1
$659K Buy
+13,562
New +$679K 0.25% 98

Other funds holding CAH

Rikoon Group's CAH Position: Q1 2021 in Review

Rikoon Group reduced its Cardinal Health (CAH) stake by 1.7% in Q1 2021, selling an estimated $12.1K and leaving 12,486 shares worth $764K. The position accounts for 0.2% of the portfolio, ranked #115.

Rikoon Group first reported a position in CAH in Q1 2019 and has held it in 9 quarters since. 802 funds tracked by Wall St. Rank hold CAH as of Q1 2021.

  • Rikoon Group held 12,486 shares of Cardinal Health worth $764K as of Q1 2021.
  • Rikoon Group sold 220 Cardinal Health shares in Q1 2021, an estimated $12.1K.
  • Cardinal Health made up 0.2% of Rikoon Group's portfolio in Q1 2021, its #115 holding.
  • Rikoon Group first reported a position in Cardinal Health in Q1 2019 and has held it in 9 quarters since.
  • 802 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2021.

Based on Rikoon Group's 13F filing for Q1 2021, filed 14 May 2021.